HomeTrading IdeasAsian Stocks Climb as...

Asian Stocks Climb as Trump Signals Openness to Trade Talks Before Tariff Deadline

Asian stock markets remained steady despite the latest update on US President Donald Trump’s tariff plans. On Tuesday, the stayed strong, and dropped.

In the US, stock prices fell after Trump sent letters to 14 countries, including Japan and South Korea, announcing much higher tariffs on imports. However, the start of these tariffs has been delayed until August 1.

Asian Market Wrap

Most Asian stock markets went up as President Trump signaled he’s open to more trade talks, easing concerns after imposing heavy tariffs on several countries.

South Korea’s stock market jumped over 1.4%, and Japan’s Nikkei-225 index rose 0.2%. The MSCI regional stock index edged up 0.1% after small ups and downs earlier in the day. The South got stronger, while the dropped 0.2%. The gained value after reports that the U.S. offered the EU a deal with a 10% tariff limit.

In Japan, government bond yields kept climbing. Meanwhile, Australia’s currency surged after the central bank surprised everyone by keeping interest rates unchanged.

European Open

Global stock markets were mostly steady or slightly higher on Tuesday as investors reacted calmly to the latest update on U.S. President Donald Trump’s tariff plans.

On Monday, Trump sent letters to 14 countries, including major Asian trade partners like Japan and South Korea, announcing much higher tariffs on imports to the US.

However, the market response has been more cautious this time, unlike the sharp drops seen three months ago on “Liberation Day.” This is because many expect countries to work on trade deals with the US before the new August 1 deadline.

In Europe, the index stayed mostly unchanged, while the euro rose 0.4%. Reports suggest the EU won’t receive a letter about higher tariffs and could finalize a trade deal by Wednesday.

The EU aims to secure a temporary trade deal with the U.S. this week, which would lock in a 10% tariff rate past the August 1 deadline while working on a long-term agreement. Meanwhile, Bulgaria is set to take the final step to join the Eurozone as its 21st member next year, with EU finance ministers meeting on Tuesday to approve its application.

On the FX front, the euro hit a one-year high against the and was last up 0.4% on the day at 171.745.

The euro rallied against the dollar as well, rising 0.4% to 1.1735, partially recouping Monday’s 0.67% loss.

The was the star performer on Tuesday, jumping over 1% after the Reserve Bank of Australia surprised markets by keeping interest rates unchanged. It was last up 0.8% at 0.6545.

The rose 0.38% to 0.60245, while the increased 0.3% to 1.3642.

China’s briefly dropped to a two-week low against the dollar due to renewed worries about US tariffs. However, it bounced back after major state-owned banks stepped in to support the currency.

Currency Power Balance

Source: OANDA Labs

Looking at commodities and oil prices have recovered following a gap down over the weekend. Markets appear to be hopeful that trade deals may spur on a bigger rally despite OPEC + further unwinding production cuts.

has also rallied following a brief foray below the 3300/oz handle. This morning Gold is a bit more tentative trading around 3320/oz which is some way off the Asian session highs around 3346/oz.

Economic Data Releases and Final Thoughts

Looking at the economic calendar, it remains a quiet one. There are no high-impact data releases from the EU, UK, or US ahead today.

Thus, I am expecting tariff and trade deal chatter to dominate matters today and for the majority of the week ahead.

We will have some comments from ECB policymaker Nagel later today while we will also get a glimpse at the number.

Inflation expectations may paint a picture for market participants especially after US Treasury Secretary Scott Bessent said the US will experience growth without inflation, something which until now has been a sticking point.

Economic Calendar

MarketPulse Economic Calendar

Chart of the Day – DAX Index

From a technical standpoint, the has been moving higher this morning on optimism that the EU will strike a deal with the Trump administration.

The EU is looking to secure a temporary deal that would cap tariffs at 10% past the August 1 deadline while working on a long-term agreement.

This appears to have given EU stocks a boost this morning and this comes despite a drop-off in both German imports and exports.

The DAX has broken above the 24000 handle with the next key resistance at 24330. A break above this level may lead to further gains, especially if the proposed 10% tariff is agreed between the EU and US.

DAX Daily Chart, July 8. 2025DAX-Daily Chart

Source: TradingView.com

Support

Resistance

Original Post

Most Popular

More from Author

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both...

Read Now

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a tipping point, the herd realizes the tide has reversed and it’s time to sell--but alas, it’s too late. Illiquid, Overvalued describes a great many assets that are on the books as "rock-solid investments." Illiquidity...

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks – Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organizations, including the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and the American Public Health Association...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a session volume of 160.9 million compared to the average volume of 4.03 million as per data from Benzinga Pro.What HappenedZyVersa Therapeutics provided regulatory and product support for FDA-authorized Emergency Compassionate Use of Cholesterol Efflux Mediator VAR 200...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both China and the EU avoid tariff letters Equities are wobbly, while gold confirms lingering demand Aussie gains as RBA surprises by keeping rates unchanged Liberation Date: Version 2The approval of the US Budget Bill has allowed US President Trump...

Wall Street Is On Fire—So Why Is This Wall Of Cash Moving Abroad? – iShares Core MSCI Emerging Markets ETF (ARCA:IEMG)

U.S. stocks may be breaking records, but a flood of investor cash is moving elsewhere—toward emerging markets, where valuations are cheaper, currencies are strengthening and years of underperformance may finally be reversing.The iShares Core MSCI Emerging Markets ETF IEMG has attracted $7.4 billion in inflows so far...

Why CARGO Therapeutics Stock Is Gaining Today – Cargo Therapeutics (NASDAQ:CRGX)

CARGO Therapeutics Inc. CRGX saw its stock climb on Tuesday after the biotech firm announced a merger agreement with Concentra Biosciences LLC.Under the terms of the agreement, Concentra will acquire CARGO for $4.379 in cash per share, along with a non-transferable contingent value right.The CVR entitles shareholders...

Gold Prices Slip Amid Trump’s Tariff Delay and Fed Rate Cut Speculations

Gold Pressured by Trade Tariffs On Monday, U.S. President Donald Trump posted letters on Truth Social addressed to the leaders of 14 countries. He threatened to impose tariffs ranging from 25% to 40% on imports unless countries address trade imbalances. The letters targeted China, Germany, Japan, Mexico, and...

Artelo Biosciences Analyst See It As An Emerging Biotech – Artelo Biosciences (NASDAQ:ARTL)

D. Boral Capital upgraded Artelo Biosciences, Inc. ARTL on Tuesday.The analyst upgraded from Hold to Buy and introduced a price forecast of $20.Analyst Jason Kolbert wrote, “We continue to view Artelo as an emerging biotechnology company focused on Cachexia and chemotherapy-induced peripheral neuropathy (CIN) with the lead...

Oil Prices Rebound Despite OPEC+ Output Hike as Markets Rethink Supply Risk

surged yesterday after gapping down over the weekend. The gap down came about as the + group, which includes OPEC and its allies, agreed to increase oil production by 548,000 barrels per day in August. This is a bigger rise compared to the 411,000 barrels per day...

Why Is Cogent Biosciences Stock Soaring On Tuesday? – Cogent Biosciences (NASDAQ:COGT)

On Monday, Cogent Biosciences, Inc. COGT said bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis.The company said that its experimental drug reduced the symptoms of a chronic immune disorder called non-advanced systemic mastocytosis.The latest study demonstrated meaningful and highly statistically significant improvements across the...

Are Markets Underpricing the Next Tariff Shock?

Economic activity appears set to strengthen in the official Q2 , but the second half of the year looks relatively vulnerable. One factor is the possibility that the simmering trade war may heat up after President Trump on Monday announced new tariffs set to begin on August...

Does Higher Dose Of Wegovy Result In More Weight Loss – Novo Nordisk (NYSE:NVO)

Novo Nordisk A/S NVO on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy (subcutaneous semaglutide 7.2 mg).The submission is based on clinical data from the STEP UP and STEP...